4.3 Article

Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption

Related references

Note: Only part of the references are listed.
Article Psychiatry

Moderation of antidepressant response by the serotonin transporter gene

Patricia Huezo-Diaz et al.

BRITISH JOURNAL OF PSYCHIATRY (2009)

Article Medical Laboratory Technology

AmpliChip CYP450 GeneChip®:: A new gene chip that allows rapid and accurate CYP2D6 genotyping

Tanja Heller et al.

THERAPEUTIC DRUG MONITORING (2006)

Article Clinical Neurology

Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population

K Wolff et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2006)

Article Genetics & Heredity

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder

XZ Hu et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2006)

Article Medicine, Legal

Ecstasy - deadly risk even outside rave parties

K Libiseller et al.

FORENSIC SCIENCE INTERNATIONAL (2005)

Article Pharmacology & Pharmacy

MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers

R de la Torre et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2005)

Article Biology

Circadian phase in adults of contrasting ages

DF Kripke et al.

CHRONOBIOLOGY INTERNATIONAL (2005)

Review Clinical Neurology

Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy

AC Parrott

JOURNAL OF PSYCHOPHARMACOLOGY (2005)

Article Clinical Neurology

Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs

JC Cole et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2005)

Article Medical Laboratory Technology

Human pharmacology of MDMA -: Pharmacokinetics, metabolism, and disposition

R de la Torre et al.

THERAPEUTIC DRUG MONITORING (2004)

Review Endocrinology & Metabolism

Cortisol pulsatility and its role in stress regulation and health

EA Young et al.

FRONTIERS IN NEUROENDOCRINOLOGY (2004)

Article Pharmacology & Pharmacy

Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine

A Heydari et al.

DRUG METABOLISM AND DISPOSITION (2004)

Article Endocrinology & Metabolism

Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines

AN Vgontzas et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Letter Pharmacology & Pharmacy

CYP2D6 deficiency, a factor in ecstasy related deaths?

TC Gilhooly et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)

Article Endocrinology & Metabolism

Immediate effects of an 8-h advance shift of the rest-activity cycle on 24-h profiles of cortisol

A Caufriez et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)

Article Substance Abuse

The subjective effects of MDMA and mCPP in moderate MDMA users

ME Tancer et al.

DRUG AND ALCOHOL DEPENDENCE (2001)

Article Chemistry, Analytical

Three cases of fatal paramethoxyamphetamine overdose

TL Martin

JOURNAL OF ANALYTICAL TOXICOLOGY (2001)

Article Multidisciplinary Sciences

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

MF Egan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Anesthesiology

Metabolic consequences of drug misuse

JA Henry

BRITISH JOURNAL OF ANAESTHESIA (2000)